Crossmark Global Holdings, Inc. Astrazeneca PLC Transaction History

Crossmark Global Holdings, Inc.

$5.61 Billion
Q3 2024

A detailed history of Crossmark Global Holdings, Inc. transactions in Astrazeneca PLC stock. As of the latest transaction made, Crossmark Global Holdings, Inc. holds 53,438 shares of AZN stock, worth $3.38 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

53,438

Previous 40,482 32.0%

Holding current value

$3.38 Million

Previous $3.16 Million 31.9%

% of portfolio

0.07%

Previous 0.06%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 04, 2024	BUY	$76.67 - $87.62 $993,336 - $1.14 Million	12,956 Added 32.0%	53,438 $4.16 Million
Q2 2024 Jul 29, 2024	BUY	$66.81 - $80.83 $87,053 - $105,321	1,303 Added 3.33%	40,482 $3.16 Million
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $80,254 - $91,484	-1,315 Reduced 3.25%	39,179 $2.65 Million
Q4 2023 Feb 13, 2024	BUY	$61.89 - $69.28 $58,733 - $65,746	949 Added 2.4%	40,494 $2.73 Million
Q3 2023 Nov 08, 2023	BUY	$64.85 - $71.7 $3,112 - $3,441	48 Added 0.12%	39,545 $2.69 Million
Q2 2023 Jul 31, 2023	BUY	$69.91 - $75.81 $119,476 - $129,559	1,709 Added 4.52%	39,497 $2.82 Million
Q1 2023 May 12, 2023	BUY	$63.15 - $71.6 $15,092 - $17,112	239 Added 0.64%	37,788 $2.62 Million
Q4 2022 Jan 19, 2023	SELL	$54.21 - $70.44 $29,923 - $38,882	-552 Reduced 1.45%	37,549 $2.55 Million
Q3 2022 Nov 01, 2022	BUY	$53.02 - $135.75 $278,408 - $712,823	5,251 Added 15.98%	38,101 $2.09 Million
Q2 2022 Jul 29, 2022	SELL	$59.26 - $71.14 $106,075 - $127,340	-1,790 Reduced 5.17%	32,850 $2.17 Million
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $163,816 - $197,332	2,940 Added 9.27%	34,640 $2.3 Million
Q3 2021 Oct 21, 2021	BUY	$55.56 - $60.79 $505,262 - $552,824	9,094 Added 40.23%	31,700 $1.9 Million
Q3 2021 Oct 13, 2021	SELL	$55.56 - $60.79 $196,904 - $215,439	-3,544 Reduced 13.55%	22,606 $541,000
Q2 2021 Jul 21, 2021	SELL	$48.42 - $60.18 $80,377 - $99,898	-1,660 Reduced 5.97%	26,150 $1.57 Million
Q1 2021 Apr 15, 2021	SELL	$47.16 - $54.44 $547,763 - $632,320	-11,615 Reduced 29.46%	27,810 $1.38 Million
Q4 2020 Jan 14, 2021	SELL	$48.52 - $58.02 $374,477 - $447,798	-7,718 Reduced 16.37%	39,425 $1.97 Million
Q3 2020 Oct 08, 2020	BUY	$53.07 - $61.1 $70,052 - $80,652	1,320 Added 2.88%	47,143 $2.58 Million
Q2 2020 Aug 14, 2020	SELL	$43.1 - $55.31 $81,243 - $104,259	-1,885 Reduced 3.95%	45,823 $2.42 Million
Q1 2020 Apr 28, 2020	BUY	$37.79 - $51.33 $85,405 - $116,005	2,260 Added 4.97%	47,708 $2.13 Million
Q4 2019 Feb 06, 2020	BUY	$42.46 - $50.46 $92,987 - $110,507	2,190 Added 5.06%	45,448 $2.27 Million
Q3 2019 Oct 09, 2019	SELL	$40.12 - $45.47 $834,094 - $945,321	-20,790 Reduced 32.46%	43,258 $1.93 Million
Q2 2019 Jul 09, 2019	BUY	$37.28 - $41.68 $101,028 - $112,952	2,710 Added 4.42%	64,048 $2.64 Million
Q1 2019 May 02, 2019	BUY	$35.49 - $43.02 $35,490 - $43,020	1,000 Added 1.66%	61,338 $2.48 Million
Q4 2018 Jan 31, 2019	SELL	$36.86 - $41.49 $28,382 - $31,947	-770 Reduced 1.26%	60,338 $2.29 Million
Q3 2018 Nov 08, 2018	BUY	$34.76 - $39.72 $847,066 - $967,936	24,369 Added 66.33%	61,108 $2.42 Million
Q2 2018 Jul 31, 2018	SELL	$34.55 - $37.05 $2.07 Million - $2.22 Million	-59,860 Reduced 61.97%	36,739 $1.29 Million
Q1 2018 Apr 16, 2018	SELL	$32.97 - $36.63 $837,503 - $930,475	-25,402 Reduced 20.82%	96,599 $3.38 Million
Q4 2017 Feb 05, 2018	SELL	$32.09 - $34.78 $17,328 - $18,781	-540 Reduced 0.44%	122,001 $4.23 Million
Q3 2016 Oct 25, 2017	BUY	N/A	122,541	122,541 $4.15 Million

Others Institutions Holding AZN

# of Institutions

1,360

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Crossmark Global Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Crossmark Global Holdings, Inc. with notifications on news.

Account

Crossmark Global Holdings, Inc. Astrazeneca PLC Transaction History